Bill Anderson
Chairman of the Board of Management and Chief Executive OfficerBayer
PharmaceuticalsView Profile →President and Chief Executive Officer · Novo Nordisk
Maziar Mike Doustdar is Novo Nordisk’s president and CEO, following a career in the company’s emerging markets and international commercial operations.
Last reviewed: Nov 15, 2026
Maziar Mike Doustdar is Novo Nordisk’s president and CEO, following a career in the company’s emerging markets and international commercial operations.
Doustdar joined Novo Nordisk in Vienna in 1992 as an office clerk. Between 1993 and 2007, he worked across finance, information technology, logistics, operations and marketing in the company’s emerging-market organisation, with postings in Vienna, Athens and Zurich.
He became general manager of the Near East business in 2007, based in Turkey, and was promoted to vice president of the business area in 2010. In 2012, he moved to Malaysia to lead Oceania and South East Asia. These assignments preceded his leadership of the wider international business.
In 2013, Doustdar became senior vice president of International Operations. Promotion to executive vice president followed in April 2015. His geographical remit expanded over the following decade; Canada joined International Operations in January 2025, leaving the organisation responsible for all commercial units outside the United States.
He became president and chief executive officer on August 7, 2025. The succession also brought changes to research leadership and the appointment of Emil Kongshøj Larsen to his former international role. Doustdar’s path to CEO combined operational postings in emerging markets with a decade leading the international commercial organisation. He earned a bachelor’s degree in international business at Webster University in Vienna in 1994.